Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program

Robert B. McLafferty, Marc A. Passman, Joseph A. Caprini, Thom W Rooke, Steven A. Markwell, Joanne M. Lohr, Mark H. Meissner, Bo G. Eklöf, Thomas W. Wakefield, Michael C. Dalsing

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the American Venous Forum. Methods: Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment, duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and a report card to give their physician. Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data observed included mean age of 60 years (range, 17-93 years); 77% female; 80% Caucasian; mean BMI of 29 (range, 11-68); 40% current or previous smoker; and 24% taking antiplatelet therapy and 4% taking warfarin. If placed in a situation conducive for VTE, 40% of participants were low risk, 22% were moderate risk, 21% were high risk, and 17% were very high risk. On a venous QOL assessment, 17% had a combined total score for all 11 questions of "very limited" or "impossible to do." Reflux or obstruction was noted in 37% and 5% of participants, respectively. CEAP class 0 to 6 was 29%, 29%, 23%, 10%, 9%, 1.5%, 0.5%, respectively. Discussion: Despite a dramatic expansion in the second annual NSVP (from 17 to 83 centers), the presence of venous disease observed in a larger screened population continues to be high. The NVSP represents one pathway to increasing public awareness about venous disease.

Original languageEnglish (US)
Pages (from-to)394-399
Number of pages6
JournalJournal of Vascular Surgery
Volume48
Issue number2
DOIs
StatePublished - Aug 2008

Fingerprint

Venous Thromboembolism
Quality of Life
Demography
Physicians
Warfarin
Population
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Increasing awareness about venous disease : The American Venous Forum expands the National Venous Screening Program. / McLafferty, Robert B.; Passman, Marc A.; Caprini, Joseph A.; Rooke, Thom W; Markwell, Steven A.; Lohr, Joanne M.; Meissner, Mark H.; Eklöf, Bo G.; Wakefield, Thomas W.; Dalsing, Michael C.

In: Journal of Vascular Surgery, Vol. 48, No. 2, 08.2008, p. 394-399.

Research output: Contribution to journalArticle

McLafferty, RB, Passman, MA, Caprini, JA, Rooke, TW, Markwell, SA, Lohr, JM, Meissner, MH, Eklöf, BG, Wakefield, TW & Dalsing, MC 2008, 'Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program', Journal of Vascular Surgery, vol. 48, no. 2, pp. 394-399. https://doi.org/10.1016/j.jvs.2008.03.041
McLafferty, Robert B. ; Passman, Marc A. ; Caprini, Joseph A. ; Rooke, Thom W ; Markwell, Steven A. ; Lohr, Joanne M. ; Meissner, Mark H. ; Eklöf, Bo G. ; Wakefield, Thomas W. ; Dalsing, Michael C. / Increasing awareness about venous disease : The American Venous Forum expands the National Venous Screening Program. In: Journal of Vascular Surgery. 2008 ; Vol. 48, No. 2. pp. 394-399.
@article{40369396b6ac4bcc9a224b6b0981e64d,
title = "Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program",
abstract = "Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the American Venous Forum. Methods: Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment, duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and a report card to give their physician. Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data observed included mean age of 60 years (range, 17-93 years); 77{\%} female; 80{\%} Caucasian; mean BMI of 29 (range, 11-68); 40{\%} current or previous smoker; and 24{\%} taking antiplatelet therapy and 4{\%} taking warfarin. If placed in a situation conducive for VTE, 40{\%} of participants were low risk, 22{\%} were moderate risk, 21{\%} were high risk, and 17{\%} were very high risk. On a venous QOL assessment, 17{\%} had a combined total score for all 11 questions of {"}very limited{"} or {"}impossible to do.{"} Reflux or obstruction was noted in 37{\%} and 5{\%} of participants, respectively. CEAP class 0 to 6 was 29{\%}, 29{\%}, 23{\%}, 10{\%}, 9{\%}, 1.5{\%}, 0.5{\%}, respectively. Discussion: Despite a dramatic expansion in the second annual NSVP (from 17 to 83 centers), the presence of venous disease observed in a larger screened population continues to be high. The NVSP represents one pathway to increasing public awareness about venous disease.",
author = "McLafferty, {Robert B.} and Passman, {Marc A.} and Caprini, {Joseph A.} and Rooke, {Thom W} and Markwell, {Steven A.} and Lohr, {Joanne M.} and Meissner, {Mark H.} and Ekl{\"o}f, {Bo G.} and Wakefield, {Thomas W.} and Dalsing, {Michael C.}",
year = "2008",
month = "8",
doi = "10.1016/j.jvs.2008.03.041",
language = "English (US)",
volume = "48",
pages = "394--399",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Increasing awareness about venous disease

T2 - The American Venous Forum expands the National Venous Screening Program

AU - McLafferty, Robert B.

AU - Passman, Marc A.

AU - Caprini, Joseph A.

AU - Rooke, Thom W

AU - Markwell, Steven A.

AU - Lohr, Joanne M.

AU - Meissner, Mark H.

AU - Eklöf, Bo G.

AU - Wakefield, Thomas W.

AU - Dalsing, Michael C.

PY - 2008/8

Y1 - 2008/8

N2 - Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the American Venous Forum. Methods: Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment, duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and a report card to give their physician. Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data observed included mean age of 60 years (range, 17-93 years); 77% female; 80% Caucasian; mean BMI of 29 (range, 11-68); 40% current or previous smoker; and 24% taking antiplatelet therapy and 4% taking warfarin. If placed in a situation conducive for VTE, 40% of participants were low risk, 22% were moderate risk, 21% were high risk, and 17% were very high risk. On a venous QOL assessment, 17% had a combined total score for all 11 questions of "very limited" or "impossible to do." Reflux or obstruction was noted in 37% and 5% of participants, respectively. CEAP class 0 to 6 was 29%, 29%, 23%, 10%, 9%, 1.5%, 0.5%, respectively. Discussion: Despite a dramatic expansion in the second annual NSVP (from 17 to 83 centers), the presence of venous disease observed in a larger screened population continues to be high. The NVSP represents one pathway to increasing public awareness about venous disease.

AB - Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the American Venous Forum. Methods: Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment, duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and a report card to give their physician. Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data observed included mean age of 60 years (range, 17-93 years); 77% female; 80% Caucasian; mean BMI of 29 (range, 11-68); 40% current or previous smoker; and 24% taking antiplatelet therapy and 4% taking warfarin. If placed in a situation conducive for VTE, 40% of participants were low risk, 22% were moderate risk, 21% were high risk, and 17% were very high risk. On a venous QOL assessment, 17% had a combined total score for all 11 questions of "very limited" or "impossible to do." Reflux or obstruction was noted in 37% and 5% of participants, respectively. CEAP class 0 to 6 was 29%, 29%, 23%, 10%, 9%, 1.5%, 0.5%, respectively. Discussion: Despite a dramatic expansion in the second annual NSVP (from 17 to 83 centers), the presence of venous disease observed in a larger screened population continues to be high. The NVSP represents one pathway to increasing public awareness about venous disease.

UR - http://www.scopus.com/inward/record.url?scp=47249116467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47249116467&partnerID=8YFLogxK

U2 - 10.1016/j.jvs.2008.03.041

DO - 10.1016/j.jvs.2008.03.041

M3 - Article

C2 - 18572373

AN - SCOPUS:47249116467

VL - 48

SP - 394

EP - 399

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 2

ER -